Chia-Hung Wu1,2,3, Chih-Ping Chung2,4, Ting-Yi Chen1, Kai-Wei Yu1,2, Te-Ming Lin1,2, Wei-An Tai1,2, Chao-Bao Luo1,2,5, Feng-Chi Chang6,7. 1. Department of Radiology, Taipei Veterans General Hospital, No. 201, Section 2, Shipai Road, Beitou District, Taipei, Taiwan, 11217. 2. School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. 3. Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. 4. Department of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan. 5. Department of Biomedical Engineering, Yuanpei University of Medical Technology, Hsinchu, Taiwan. 6. Department of Radiology, Taipei Veterans General Hospital, No. 201, Section 2, Shipai Road, Beitou District, Taipei, Taiwan, 11217. fcchang374@gmail.com. 7. School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. fcchang374@gmail.com.
Abstract
OBJECTIVES: To investigate whether the imaging changes on high-resolution vessel wall imaging (HR-VWI) in patients before and after percutaneous transluminal angioplasty and stenting (PTAS) contribute to predicting the clinical outcome. METHODS: The study included 24 severe intracranial artery stenosis (SICAS) patients undergoing PTAS with Wingspan Stent between 2018 and 2020 and had a 1-year follow-up. Three HR-VWI sessions (preprocedural, early [within 24 h], and delayed postprocedural [134.7 ± 27.1 days)]) in each subject were performed with 3-Tesla MRI. We evaluated periprocedural HR-VWI changes in patients with and without recurrent cerebral ischemic symptoms (RCIS) within 1-year follow-up. RESULTS: On CE-T1WI of the patients without RCIS, a significant decrease in enhanced area was observed on early postprocedural (0.04 ± 0.02 cm2, p = 0.001) and delayed postprocedural (0.04 ± 0.02 cm2; p = 0.001) HR-VWI compared to preprocedural (0.07 ± 0.02 cm2) HR-VWI. Patients with RCIS demonstrated no significant loss of enhanced area on CE-T1WI of early postprocedural HR-VWI (p = 0.180). Significant decreases in calibrated T1 signals were observed in both presence (1.77 ± 0.70 vs. 0.79 ± 0.52; p = 0.018) and absence (1.42 ± 0.62 vs. 0.83 ± 0.40; p = 0.001) of RCIS in early postprocedural HR-VWI. CONCLUSION: The preliminary results showed the presence of reduced contrast enhancement immediately after PTAS may indicate less recurrent stroke events within 1 year. Further studies are necessary to confirm the phenomena in a longer observation period. KEY POINTS: • Early postprocedural high-resolution vessel imaging (HR-VWI) within 24 h can effectively predict a 1-year outcome following intracranial stenting. • For stenotic lesions after stenting without reduced contrast enhancement on HR-VWI within 24 h may need closer clinical surveillance for potentially higher risk of stroke events within 1 year.
OBJECTIVES: To investigate whether the imaging changes on high-resolution vessel wall imaging (HR-VWI) in patients before and after percutaneous transluminal angioplasty and stenting (PTAS) contribute to predicting the clinical outcome. METHODS: The study included 24 severe intracranial artery stenosis (SICAS) patients undergoing PTAS with Wingspan Stent between 2018 and 2020 and had a 1-year follow-up. Three HR-VWI sessions (preprocedural, early [within 24 h], and delayed postprocedural [134.7 ± 27.1 days)]) in each subject were performed with 3-Tesla MRI. We evaluated periprocedural HR-VWI changes in patients with and without recurrent cerebral ischemic symptoms (RCIS) within 1-year follow-up. RESULTS: On CE-T1WI of the patients without RCIS, a significant decrease in enhanced area was observed on early postprocedural (0.04 ± 0.02 cm2, p = 0.001) and delayed postprocedural (0.04 ± 0.02 cm2; p = 0.001) HR-VWI compared to preprocedural (0.07 ± 0.02 cm2) HR-VWI. Patients with RCIS demonstrated no significant loss of enhanced area on CE-T1WI of early postprocedural HR-VWI (p = 0.180). Significant decreases in calibrated T1 signals were observed in both presence (1.77 ± 0.70 vs. 0.79 ± 0.52; p = 0.018) and absence (1.42 ± 0.62 vs. 0.83 ± 0.40; p = 0.001) of RCIS in early postprocedural HR-VWI. CONCLUSION: The preliminary results showed the presence of reduced contrast enhancement immediately after PTAS may indicate less recurrent stroke events within 1 year. Further studies are necessary to confirm the phenomena in a longer observation period. KEY POINTS: • Early postprocedural high-resolution vessel imaging (HR-VWI) within 24 h can effectively predict a 1-year outcome following intracranial stenting. • For stenotic lesions after stenting without reduced contrast enhancement on HR-VWI within 24 h may need closer clinical surveillance for potentially higher risk of stroke events within 1 year.
Authors: Amin Aghaebrahim; Guilherme Jose Agnoletto; Pedro Aguilar-Salinas; Manuel F Granja; Andre Monteiro; Adnan H Siddiqui; Elad I Levy; Hussain Shallwani; Song J Kim; Diogo C Haussen; Raul G Nogueira; Demetrius Lopes; Ahmed Saied; Tudor G Jovin; Ashutosh P Jadhav; Kaustubh Limaye; Aquilla S Turk; Alejandro M Spiotta; Mohammad I Chaudry; Raymond D Turner; Leonardo B C Brasiliense; Travis M Dumont; Jacob Cherian; Peter Kan; Eric Sauvageau; Ricardo A Hanel Journal: World Neurosurg Date: 2018-12-18 Impact factor: 2.104
Authors: Michael J Alexander; Alois Zauner; John C Chaloupka; Blaise Baxter; Richard C Callison; Rishi Gupta; Shlee S Song; Wengui Yu Journal: Stroke Date: 2019-04 Impact factor: 7.914
Authors: C Roth; P Papanagiotou; S Behnke; S Walter; A Haass; C Becker; K Fassbender; M Politi; H Körner; M-S Romann; W Reith Journal: Stroke Date: 2010-10-14 Impact factor: 7.914
Authors: Marc I Chimowitz; Michael J Lynn; Colin P Derdeyn; Tanya N Turan; David Fiorella; Bethany F Lane; L Scott Janis; Helmi L Lutsep; Stanley L Barnwell; Michael F Waters; Brian L Hoh; J Maurice Hourihane; Elad I Levy; Andrei V Alexandrov; Mark R Harrigan; David Chiu; Richard P Klucznik; Joni M Clark; Cameron G McDougall; Mark D Johnson; G Lee Pride; Michel T Torbey; Osama O Zaidat; Zoran Rumboldt; Harry J Cloft Journal: N Engl J Med Date: 2011-09-07 Impact factor: 91.245
Authors: Tanya N Turan; Osama O Zaidat; Gary S Gronseth; Marc I Chimowitz; Antonio Culebras; Anthony J Furlan; Larry B Goldstein; Nestor R Gonzalez; Julius G Latorre; Steven R Messé; Thanh N Nguyen; Rajbeer S Sangha; Michael J Schneck; Aneesh B Singhal; Lawrence R Wechsler; Alejandro A Rabinstein; Mary Dolan O'Brien; Heather Silsbee; Jeffrey J Fletcher Journal: Neurology Date: 2022-03-22 Impact factor: 9.910
Authors: Christian Paul Stracke; Jens Fiehler; Lukas Meyer; Götz Thomalla; Lars Udo Krause; Stephan Lowens; Jan Rothaupt; Byung Moon Kim; Ji Hoe Heo; Leonard L L Yeo; Tommy Andersson; Christoph Kabbasch; Franziska Dorn; Rene Chapot; Uta Hanning Journal: J Am Heart Assoc Date: 2020-03-03 Impact factor: 5.501